The technique designed to help families with mitochondrial conditions, 3-Parent IVF, has been questioned by British Government over the concern of passing on incurable diseases. Currently in its research stage, the potential treatment involves implantation of genetically modified embryos into women for the first time.
The technique is known as three-parent in vitro fertilisation (IVF), as the offspring would have genes of three individuals, a mother, a father and a female donor. The fertility treatment involves intervening in the fertilisation process and removing faulty mitochondrial DNA.
Owing to consequences in perpetuity, which include several inherited conditions such as fatal heart problems, blindness, muscular weakness, liver failure and brain disorders, makes it questionable.
Human Fertilisation and Embryology Authority (HFEA) is currently conducting the consultation with researchers, keeping a watch on ethical concerns and safety.
The technique is known as three-parent in vitro fertilisation (IVF), as the offspring would have genes of three individuals, a mother, a father and a female donor. The fertility treatment involves intervening in the fertilisation process and removing faulty mitochondrial DNA.
Owing to consequences in perpetuity, which include several inherited conditions such as fatal heart problems, blindness, muscular weakness, liver failure and brain disorders, makes it questionable.
Human Fertilisation and Embryology Authority (HFEA) is currently conducting the consultation with researchers, keeping a watch on ethical concerns and safety.
